Literature DB >> 8800743

Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors.

J K Kolls1, D Lei, G Odom, S Nelson, W R Summer, M A Gerber, J E Shellito.   

Abstract

E1-deleted adenoviral vectors are increasingly being utilized for in vivo gene transfer. The potential use of these vectors is limited by transient expression of the transgene and a markedly reduced rate of transduction following readministration, presumably due to a host immune response to the vector. We hypothesized that CD4+ lymphocytes are necessary to generate an immune response to these vectors and that administration of a depleting anti-CD4 antibody (GK1.5) might prolong transgene expression in vivo. We found that pretreatment of mice with a single injection (transient depletion) or weekly injections of GK1.5 (persistent depletion), markedly prolonged expression of an adenovirus-encoded tumor necrosis factor (TNF) inhibitor or luciferase gene compared to controls. Moreover, mice treated with GK1.5 showed no antiadenoviral antibody response to repeat administration of the vector and a second adenoviral transgene could be expressed in these animals. However, control mice developed a significant neutralizing antibody response that prevented transgene expression with administration of a second adenovirus. These findings demonstrate that manipulation of the host immune response may expand potential applications of gene transfer utilizing adenoviral vectors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800743     DOI: 10.1089/hum.1996.7.4-489

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.

Authors:  K B Elkon; C C Liu; J G Gall; J Trevejo; M W Marino; K A Abrahamsen; X Song; J L Zhou; L J Old; R G Crystal; E Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver.

Authors:  J T Bruder; T Jie; D L McVey; I Kovesdi
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.

Authors:  H G Zhang; G Bilbao; T Zhou; J L Contreras; J Gómez-Navarro; M Feng; I Saito; J D Mountz; D T Curiel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

4.  Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo.

Authors:  D E Brough; C Hsu; V A Kulesa; G M Lee; L J Cantolupo; A Lizonova; I Kovesdi
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.

Authors:  Kendra M Viner; Natasha Girgis; Heesun Kwak; Stuart N Isaacs
Journal:  Virology       Date:  2006-12-26       Impact factor: 3.616

6.  Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic bcl-2 gene.

Authors:  G Bilbao; J L Contreras; H G Zhang; M J Pike; K Overturf; G Mikheeva; V Krasnykh; D T Curiel
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.

Authors:  B G Harvey; N R Hackett; T El-Sawy; T K Rosengart; E A Hirschowitz; M D Lieberman; M L Lesser; R G Crystal
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.

Authors:  R J Parks; J L Bramson; Y Wan; C L Addison; F L Graham
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Interleukin-12 and host defense against murine Pneumocystis pneumonia.

Authors:  Sanbao Ruan; Laura McKinley; Mingquan Zheng; Xiaowen Rudner; Alain D'Souza; Jay K Kolls; Judd E Shellito
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

10.  Vector modifications to eliminate transposase expression following piggyBac-mediated transgenesis.

Authors:  Syandan Chakraborty; HaYeun Ji; Jack Chen; Charles A Gersbach; Kam W Leong
Journal:  Sci Rep       Date:  2014-12-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.